EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment

Chang Hoon Lee iD, Tuan Minh Nguyen iD, Yongook Lee, Seoung Gyu Choi, Phuong Ngan Nguyen, Jung Ho Park, Mi Kyung Park iD

International Journal of Molecular Sciences · 29.12.2025 · 27 (1) · 357

DOI: 10.3390/ijms27010357 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.12.2025. Verfasst von Chang Hoon Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Senescence-Associated Secretory Phenotype, Cellular Senescence, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program through the NRF, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence, initially regarded as a potent tumor-suppressive mechanism, is now recognized as a double-edged sword that modulates the hallmarks of cancer. The tumor suppressor p53 typically orchestrates this process to inhibit tumorigenesis; however, mutations in p53 or its regulators can subvert this program, leading to senescence evasion and therapy resistance. In particular, therapy-induced senescence can paradoxically drive tumor progression via the senescence-associated secretory phenotype, which creates a pro-tumorigenic microenvironment dictated by p53-mediated regulation of NF-κB signaling. Here, we explore the p53-mediated senescence–cancer interplay and evaluate emerging therapies, including senolytics and immunotherapies. We propose that strategic modulation of senescence offers a promising paradigm for future anticancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Senescence-Associated Secretory PhenotypeCellular SenescenceNeoplasmsHumansAnimalsSignal TransductionDisease ProgressionImmunotherapy

Stichwörter der Autor:innen

cancer immunotherapycellular senescencep53senescence-associated secretory phenotype (SASP)senolyticssenomorphicstherapy-induced senescence (TIS)

Substanzen

Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Goyang 10326, Republic of Korea.
  • Department of Biomedical Science, Hwasung Medi-Science University, Hwaseong-si 18274, Republic of Korea.

ORCID-Profile: Chang Hoon Lee, Tuan Minh Nguyen, Mi Kyung Park

Förderung

  • Basic Science Research Program through the NRF
  • Ministry of Education

Zitieren

APA

Lee, C. H., Minh Nguyen, T., Lee, Y., Choi, S. G., Nguyen, P. N., Park, J. H., & Park, M. K. (2025). Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment. International Journal of Molecular Sciences, 27(1), 357. https://doi.org/10.3390/ijms27010357

Vancouver

Lee CH, Minh Nguyen T, Lee Y, Choi SG, Nguyen PN, Park JH, et al. Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment. International Journal of Molecular Sciences. 2025;27(1):357. doi:10.3390/ijms27010357

BibTeX
@article{Lee2025,
  author = {Lee, Chang Hoon and Minh Nguyen, Tuan and Lee, Yongook and Choi, Seoung Gyu and Nguyen, Phuong Ngan and Park, Jung Ho and Park, Mi Kyung},
  title = {Therapy-Induced Senescence (TIS) and SASP: The p53-Mediated Interplay in Cancer Progression and Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {27},
  number = {1},
  pages = {357},
  doi = {10.3390/ijms27010357}
}
Kostenlos starten →